ロード中...
Indian pharmaceutical patent prosecution: The changing role of Section 3(d)
India, like many developing countries, only recently began to grant pharmaceutical product patents. Indian patent law includes a provision, Section 3(d), which tries to limit grant of “secondary” pharmaceutical patents, i.e. patents on new forms of existing molecules and drugs. Previous research sug...
保存先:
| 出版年: | PLoS One |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5880378/ https://ncbi.nlm.nih.gov/pubmed/29608604 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0194714 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|